Status:
UNKNOWN
A Registry Study on Serumal Biomarkers About Adverse Events in Patients Undergoing Coronary Artery Bypass Grafting.
Lead Sponsor:
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Conditions:
Cardiac Surgery
Eligibility:
All Genders
18-80 years
Brief Summary
This is a national registry study to determine the serumal biomarkers for prognosis of adverse events in patients undergoing coronary artery bypass grafting.
Eligibility Criteria
Inclusion
- Subject undergoing coronary artery bypass grafting;
- Age is more than 18 and less than 80 years old;
- Male and non pregnancy female;
- Subject who understands study requirements and agrees to sign an informed consent from prior to study procedures.
Exclusion
- Pregnancy female;
- Participate in other clinical trial in the last 1 month.
- Subject who doesn't agree to sign an informed consent from prior to study procedures.
- Subject undergoing repeat CABG, concomitant valve or other cardiac surgery.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04107571
Start Date
January 1 2019
End Date
June 1 2024
Last Update
September 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Anzhen Hospital
Beijing, China, 100029